Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
George, P. M., Wells, A. U., & Jenkins, R. G. (2020). Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Life Sciences Papers Related to COVID-19 Human Physiology
International Journal of Antimicrobial Agents Papers Related to COVID-19 Human Physiology
Cytokine & Growth Factor Reviews Papers Related to COVID-19 Human Physiology
Brain, Behavior, and Immunity Papers Related to COVID-19 Human Physiology
Journal of Autoimmunity Papers Related to COVID-19 Human Physiology
Obesity Medicine Papers Related to COVID-19 Human Physiology
Pediatric Clinics of North America Articles Related to COVID-19 Human Physiology
Thrombosis Research Papers Related to Human Physiology of COVID-19
Autoimmunity Review Papers Related to COVID-19 Human Physiology
Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response
Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19
Assessment of Small Pulmonary Blood Vessels in COVID-19 Patients Using HRCT
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Nutrition Papers Related to COVID-19 Human Physiology
Biochemical and Biophysical Research Communications Papers Related to COVID-19 Human Physiology